Vildagliptin [vildagliptin]
- Terms
-
(S)-1-[N-(3-hydroxy-1-adamantyl)glycyl]pyrolidin-2-karbonitril
Galvus
-
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
Galvus
NVP-LAF237
A pyrrolidine-carbonitrile derivative and potent inhibitor of DIPEPTIDYL PEPTIDASE 4 that is used in the treatment of TYPE 2 DIABETES MELLITUS.
- DUI
- D000077597 MeSH Browser
- CUI
- M0486919
- History note
- 2019 (2005)
- Public note
- 2019; VILDAGLIPTIN was indexed under NITRILES and PYRROLIDINES 2005-2018
Allowable subheadings
- AD
- administration & dosage 8
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 7
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 16
- TO
- toxicity
- UR
- urine
lipoyl vildagliptin Chemical MeSH Browser